Cytokine Elisa Laboratories manufactures the bispecific antibody cytokine elisa reagents distributed by Genprice. The Bispecific Antibody Cytokine Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytokine elisa. Other Bispecific products are available in stock. Specificity: Bispecific Category: Antibody Group: Cytokine Elisa
Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body) |
|||
| TRIB-356-100ug | Creative Biolabs | 100μg | EUR 4028 |
|
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy. |
|||
Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body) |
|||
| TRIB-356-50ug | Creative Biolabs | 50μg | EUR 2507 |
|
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy. |
|||
Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (Bi-nanobody) |
|||
| BIVHH-008 | Creative Biolabs | 200μg | Ask for price |
|
Description: A bispecific antibody that is expressed as an anti-Ang2 nanobody (VHH) fused with an anti-VEGFA nanobody (VHH), contains a His-tag at the C/N terminus for affinity purification. This BsAb is capable of inhibiting two proangiogenics fators. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy. |
|||
Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (Bi-nanobody) |
|||
| BIVHH-176 | Creative Biolabs | 200μg | Ask for price |
|
Description: A bispecific antibody that is expressed as an anti-IL17A nanobody (VHH) fused with an anti-IL17F nanobody (VHH), contains a His-tag at the C/N terminus for affinity purification. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Multiple sclerosis (MS); Autoimmune diseases; Inflammatory diseases therapy. |
|||
Recombinant Anti-HER2 x Anti-mCD3 Bispecific Antibody (KIH-IgG) |
|||
| BSAB-002-100ug | Creative Biolabs | 100μg | EUR 4028 |
|
Description: A bispecific antibody that is consisted of one half of anti-human HER2 IgG and one hlaf of anti-mouse CD3 IgG.his BsAb is designed to explore the effect of the anti-HER2 antibody in mouse model. |
|||
Recombinant Anti-HER2 x Anti-mCD3 Bispecific Antibody (KIH-IgG) |
|||
| BSAB-002-50ug | Creative Biolabs | 50μg | EUR 2507 |
|
Description: A bispecific antibody that is consisted of one half of anti-human HER2 IgG and one hlaf of anti-mouse CD3 IgG.his BsAb is designed to explore the effect of the anti-HER2 antibody in mouse model. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
|||
| BSFAB-046-100ug | Creative Biolabs | 100μg | EUR 3911 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
|||
| BSFAB-046-50ug | Creative Biolabs | 50μg | EUR 2390 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-020-100ug | Creative Biolabs | 100μg | EUR 3560 |
|
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy. |
|||
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-020-50ug | Creative Biolabs | 50μg | EUR 2039 |
|
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy. |
|||
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-030-100ug | Creative Biolabs | 100μg | EUR 3560 |
|
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy. |
|||
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-030-50ug | Creative Biolabs | 50μg | EUR 2039 |
|
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy. |
|||
Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-041-100ug | Creative Biolabs | 100μg | EUR 3794 |
|
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy. |
|||
Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-041-50ug | Creative Biolabs | 50μg | EUR 2156 |
|
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
|||
| BSFV-046-100ug | Creative Biolabs | 100μg | EUR 3560 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
|||
| BSFV-046-50ug | Creative Biolabs | 50μg | EUR 2039 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-066-100ug | Creative Biolabs | 100μg | EUR 3560 |
|
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy. |
|||